Regorafenib Eye Drops Show Promise in Primate AMD Model

by Medscape • 2015/05/15 • 0 Comments

Regorafenib eye drops may become a 'valuable extension' to current treatment options for wet age-related macular degeneration. However, the project is in an early development phase.
Medscape Medical News

Full Story →

← Ocular TherapeutixTM Announces Plans to Proceed with an NDA Submission for OTX-DP for Treatment of Post-Surgical Ocular Pain Indication; Reports First Quarter 2015 Financial Results

Injectable hydrogel boosts stem cell therapy to restore vision, repair brain damage →

Post navigation